Guillaume Gorincour,
Audrey Aschero,
Catherine Desvignes,
François Portier,
Brigitte Bourlière-Najean, Alix Ruocco-Angari,
Philippe Devred,
Nathalie Colavolpe,
Bertrand Roquelaure,
Arnaud Delarue,
Philippe Petit
[show abstract]
[hide abstract]
ABSTRACT: Approximately one fourth of cases of inflammatory bowel disease (IBD) occur during childhood and children are more prone than their adult counterparts to have severe disease at presentation. To investigate these diseases MR imaging is no longer an emerging tool. Numerous reviews and articles have been published on this topic underlying the advances of imaging but also the complexity and the financial impact on management of such diseases. In children it seems reasonable to consider US as the first imaging examination to perform, especially when the diagnosis of IBD is unknown. However, we believe that recent and future technical progress, especially the ability of MR to display reproducible data, and the need for gold standard evaluation of new medical therapies will increase the role of MR enterography.
Pediatric Radiology 06/2010; 40(6):920-6. · 1.67 Impact Factor
